iTeos Therapeutics, Inc. (ITOS)
USD 5.41
(-5.09%)
USD 5.41
(-5.09%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -245.11 Million USD | 12.5% |
| 2022 | -280.13 Million USD | 66.78% |
| 2021 | -843.19 Million USD | -150.71% |
| 2020 | -336.32 Million USD | -2224.62% |
| 2019 | -14.46 Million USD | 7.63% |
| 2018 | -15.66 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -245.58 Million USD | -74.39% |
| 2024 Q1 | -140.82 Million USD | 42.55% |
| 2023 Q1 | -220.73 Million USD | 21.2% |
| 2023 Q4 | -245.11 Million USD | -23.67% |
| 2023 FY | -245.11 Million USD | 12.5% |
| 2023 Q2 | -210.76 Million USD | 4.52% |
| 2023 Q3 | -198.2 Million USD | 5.96% |
| 2022 Q3 | -747.74 Million USD | 4.99% |
| 2022 Q1 | -818.73 Million USD | 2.9% |
| 2022 FY | -280.13 Million USD | 66.78% |
| 2022 Q4 | -280.13 Million USD | 62.54% |
| 2022 Q2 | -787.05 Million USD | 3.87% |
| 2021 Q1 | -318.33 Million USD | 5.35% |
| 2021 FY | -843.19 Million USD | -150.71% |
| 2021 Q4 | -843.19 Million USD | 5.99% |
| 2021 Q3 | -896.89 Million USD | -199.09% |
| 2021 Q2 | -299.87 Million USD | 5.8% |
| 2020 Q1 | -147.73 Million USD | -643.57% |
| 2020 Q4 | -336.32 Million USD | 1.08% |
| 2020 Q3 | -339.98 Million USD | -148.4% |
| 2020 Q2 | -136.87 Million USD | 7.35% |
| 2020 FY | -336.32 Million USD | -2224.62% |
| 2019 Q4 | -19.86 Million USD | 0.0% |
| 2019 FY | -14.46 Million USD | 7.63% |
| 2018 FY | -15.66 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | -338.182% |
| Alkermes plc | -166.73 Million USD | -47.008% |
| Agenus Inc. | 274.13 Million USD | 189.415% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 113.108% |
| Aptorum Group Limited | 1.35 Million USD | 18162.689% |
| Ardelyx, Inc. | 34.51 Million USD | 810.243% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 5827.079% |
| Bicycle Therapeutics plc | -481.46 Million USD | 49.089% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 777.817% |
| ChromaDex Corporation | -24.04 Million USD | -919.291% |
| Chimerix, Inc. | -25.51 Million USD | -860.611% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 3617.743% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -935.262% |
| CRISPR Therapeutics AG | -150.84 Million USD | -62.497% |
| Precision BioSciences, Inc. | -85.41 Million USD | -186.991% |
| Dyadic International, Inc. | -6.37 Million USD | -3743.136% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -1438.436% |
| Fortress Biotech, Inc. | 7.66 Million USD | 3297.9% |
| Lantern Pharma Inc. | -21.7 Million USD | -1029.41% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -121.753% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -2769.179% |
| Incyte Corporation | -3.17 Billion USD | 92.28% |
| IO Biotech, Inc. | -140.69 Million USD | -74.215% |
| Jaguar Health, Inc. | 29.39 Million USD | 933.993% |
| Novavax, Inc. | -298.29 Million USD | 17.826% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 4692.824% |
| Opthea Limited | 28.15 Million USD | 970.53% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -1359.998% |
| ContextLogic Inc. | -232 Million USD | -5.655% |
| MiMedx Group, Inc. | -33.9 Million USD | -623.044% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 2504.306% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -10479.031% |
| NextCure, Inc. | -6.47 Million USD | -3684.453% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -385.375% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -3742.593% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 2115.24% |
| Vaxcyte, Inc. | -368.22 Million USD | 33.433% |
| PDS Biotechnology Corporation | -32.7 Million USD | -649.395% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 1518.677% |
| Pharming Group N.V. | 109.8 Million USD | 323.233% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -1309.054% |
| Avidity Biosciences, Inc. | -175.23 Million USD | -39.884% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -1223.547% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -1223.547% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -3352.38% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -4082.918% |
| Acelyrin, Inc. | -216.9 Million USD | -13.009% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -4269.115% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -14118.039% |
| Summit Therapeutics Inc. | 34.67 Million USD | 806.924% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -3503.102% |
| Senti Biosciences, Inc. | 1.74 Million USD | 14187.299% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | -32.779% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -216.483% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -3943.533% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 245786.536% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 39131.688% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -109.421% |
| Wave Life Sciences Ltd. | -168.23 Million USD | -45.702% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 321.087% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -3126.948% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -89.847% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 3655.233% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | -1.137% |
| Immix Biopharma, Inc. | -17.5 Million USD | -1299.897% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 22.603% |
| MEI Pharma, Inc. | -3.7 Million USD | -6515.897% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 2059.228% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 251.549% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 981.945% |
| Fortress Biotech, Inc. | 7.66 Million USD | 3297.9% |
| Precigen, Inc. | -481 Thousand USD | -50860.291% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 1840.778% |
| AlloVir, Inc. | -62.69 Million USD | -290.989% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -340.751% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 497.495% |
| ImmuCell Corporation | 10.99 Million USD | 2330.268% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | -59.017% |
| Onconetix, Inc. | 5.33 Million USD | 4697.616% |
| PureTech Health plc | -167.19 Million USD | -46.605% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -704.724% |
| Elevation Oncology, Inc. | -19.11 Million USD | -1182.137% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -4893.257% |
| Seer, Inc. | -4.24 Million USD | -5681.108% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -919.757% |
| Innoviva, Inc. | 255.56 Million USD | 195.913% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -338.778% |
| ESSA Pharma Inc. | -33.62 Million USD | -629.053% |
| GlycoMimetics, Inc. | -40.98 Million USD | -498.078% |
| GT Biopharma, Inc. | -1.02 Million USD | -23907.738% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -261.623% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 500.149% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -82.817% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -1669.046% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -748.985% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -325276.324% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -694.242% |
| Aptose Biosciences Inc. | -8.19 Million USD | -2891.132% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -7733.736% |
| Soligenix, Inc. | -4.95 Million USD | -4850.302% |
| Century Therapeutics, Inc. | 847 Thousand USD | 29039.669% |
| Kura Oncology, Inc. | -20.11 Million USD | -1118.406% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -498.932% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -2818.778% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 13555.546% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -7567.157% |
| Autolus Therapeutics plc | -186.59 Million USD | -31.361% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -397.158% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 11.122% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 815.3% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 249.128% |
| GRI Bio, Inc. | -1.79 Million USD | -13563.266% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -2628.685% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -637.045% |
| IGM Biosciences, Inc. | -72.6 Million USD | -237.602% |
| INmune Bio, Inc. | -25.41 Million USD | -864.618% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 262.383% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -383.861% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -1408.483% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -8396.544% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 744.795% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -495.166% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 868.76% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 164.855% |
| Verastem, Inc. | -37.27 Million USD | -557.543% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -2601.631% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -372.637% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -1519.551% |
| Histogen Inc. | -7.48 Million USD | -3173.928% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -1034.452% |
| Surrozen, Inc. | -32.66 Million USD | -650.426% |
| Organovo Holdings, Inc. | -1.5 Million USD | -16165.362% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -5731.324% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 1392.808% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 9469.992% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 5997.955% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -2824.646% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -464.244% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -1581.562% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 22.624% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -33847.179% |
| Apollomics, Inc. | -27.39 Million USD | -794.758% |
| Amarin Corporation plc | -191.04 Million USD | -28.308% |
| Mesoblast Limited | 55.96 Million USD | 538.002% |
| Turnstone Biologics Corp. | -14.58 Million USD | -1580.739% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -869.156% |
| Synaptogenix, Inc. | -28.66 Million USD | -755.22% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -26087.927% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 602.994% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -28333.143% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -3273.47% |
| Exelixis, Inc. | -73.05 Million USD | -235.55% |
| Better Therapeutics, Inc. | -860 Thousand USD | -28402.209% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -920.776% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | -1.553% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 33401.226% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -3195.436% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 19646.97% |
| Gritstone bio, Inc. | 39.49 Million USD | 720.712% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -191.458% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -9212.537% |
| Avid Bioservices, Inc. | 169.72 Million USD | 244.419% |
| Insmed Incorporated | 721.62 Million USD | 133.968% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -2581.384% |
| MediWound Ltd. | -5.32 Million USD | -4505.769% |
| OmniAb, Inc. | 9.2 Million USD | 2763.468% |
| Alector, Inc. | -35.63 Million USD | -587.822% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 385.118% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -4874.006% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 1951.492% |
| Zai Lab Limited | -775 Million USD | 68.372% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 171.976% |
| Aura Biosciences, Inc. | -21.52 Million USD | -1038.764% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -197.186% |
| Immunic, Inc. | -45.34 Million USD | -440.624% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | -26.863% |
| Veracyte, Inc. | -203.82 Million USD | -20.26% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 138.402% |
| FibroGen, Inc. | 56.76 Million USD | 531.798% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 2852.6% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -8570.389% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -11739.507% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 105.34% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -7236.696% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | -47.694% |
| TG Therapeutics, Inc. | 17.86 Million USD | 1472.293% |
| Galecto, Inc. | -21.21 Million USD | -1055.35% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -930.561% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 115.619% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -901.63% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -2030.173% |
| XBiotech Inc. | -200.02 Million USD | -22.545% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -191.458% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 5513.405% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -595.117% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -217.438% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 4407.134% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | -43.837% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -165.355% |
| Vaxxinity, Inc. | 10.13 Million USD | 2519.256% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 133.292% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -2176.46% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -271.64% |
| NexImmune, Inc. | -3.13 Million USD | -7722.174% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -6999.398% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -1522.075% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -804.498% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -2630.811% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -196664.198% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -504.158% |
| Ainos, Inc. | 4.07 Million USD | 6110.871% |
| Pluri Inc. | 22.82 Million USD | 1173.718% |
| Prothena Corporation plc | -608.34 Million USD | 59.707% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -106.406% |
| Celularity Inc. | 65.19 Million USD | 476.007% |
| Rallybio Corporation | -24.1 Million USD | -917.007% |
| Cue Biopharma, Inc. | -33.81 Million USD | -624.797% |
| MeiraGTx Holdings plc | -40.3 Million USD | -508.206% |
| Omeros Corporation | 331.17 Million USD | 174.015% |
| Humacyte, Inc. | -22.48 Million USD | -990.096% |
| Immunocore Holdings plc | -358.59 Million USD | 31.644% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -897.432% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -693.24% |
| Blueprint Medicines Corporation | 702.83 Million USD | 134.876% |
| CalciMedica, Inc. | -5.53 Million USD | -4332.532% |
| Cabaletta Bio, Inc. | -188.22 Million USD | -30.23% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -2299.834% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -512.231% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -637.133% |
| Pulmatrix, Inc. | -10.41 Million USD | -2253.067% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -4001.037% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -542.649% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -120.031% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -308.913% |
| Cytokinetics, Incorporated | 642.37 Million USD | 138.158% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -4109.497% |
| Nutriband Inc. | -251.65 Thousand USD | -97302.019% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -618.424% |
| Vor Biopharma Inc. | 4.3 Million USD | 5800.442% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 95.939% |
| Evogene Ltd. | -19.63 Million USD | -1148.441% |
| ProKidney Corp. | -56.23 Million USD | -335.876% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -403.614% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -2553.611% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 117.972% |
| CorMedix Inc. | -43.05 Million USD | -469.349% |
| BioLineRx Ltd. | 7.33 Million USD | 3441.317% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -792.478% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 631.17% |
| Atai Life Sciences N.V. | -28.55 Million USD | -758.32% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 11089.277% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -974.329% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 1482.12% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -226.503% |
| MediciNova, Inc. | -50.78 Million USD | -382.674% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -211.045% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -1089559.924% |
| GeoVax Labs, Inc. | -6.45 Million USD | -3698.77% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | -22.669% |
| Biomea Fusion, Inc. | -166.57 Million USD | -47.157% |
| PTC Therapeutics, Inc. | -178.97 Million USD | -36.957% |
| Mereo BioPharma Group plc | -51.46 Million USD | -376.246% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -158.444% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 16.558% |
| Absci Corporation | -72.59 Million USD | -237.639% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 5468.353% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | -4.556% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -160.181% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -156.143% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -527.336% |
| Allakos Inc. | -24.97 Million USD | -881.457% |
| Imunon, Inc. | -4.21 Million USD | -5716.982% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -1562.726% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -81.033% |
| BioAtla, Inc. | -109.01 Million USD | -124.857% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 33401.226% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -26004.26% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 2148.462% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -1056.058% |
| XOMA Corporation | -29 Million USD | -745.238% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -1380.187% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -2618.711% |
| aTyr Pharma, Inc. | -7.44 Million USD | -3190.63% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -96.668% |
| Akero Therapeutics, Inc. | -208.16 Million USD | -17.753% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -199.733% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -164.242% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -28429.279% |
| Akari Therapeutics, Plc | -3.84 Million USD | -6275.007% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 15203.858% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 117.751% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -20530.568% |
| UroGen Pharma Ltd. | 4.39 Million USD | 5682.305% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 316.0% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 340722.829% |
| Orgenesis Inc. | 21.78 Million USD | 1225.225% |
| Entera Bio Ltd. | -10.62 Million USD | -2206.134% |
| GH Research PLC | -78.07 Million USD | -213.945% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -999.78% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -819.461% |
| Xencor, Inc. | 29.64 Million USD | 926.876% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -12343.776% |
| Replimune Group, Inc. | 1.41 Million USD | 17459.703% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -99986.155% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -93.897% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -20530.568% |
| Portage Biotech Inc. | -4.98 Million USD | -4821.08% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -1089559.924% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -270.707% |
| OncoCyte Corporation | -6.56 Million USD | -3634.862% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 27413.957% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -5280.558% |
| Purple Biotech Ltd. | -14.13 Million USD | -1633.76% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -931.819% |
| scPharmaceuticals Inc. | -6.54 Million USD | -3645.134% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -1368.467% |
| HilleVax, Inc. | -165.48 Million USD | -48.122% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -9557.959% |
| Tharimmune, Inc. | -10.93 Million USD | -2141.528% |
| Genprex, Inc. | -6.73 Million USD | -3538.06% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 33.537% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -177.096% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -17396.003% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -7289.9% |
| OKYO Pharma Limited | -826.84 Thousand USD | -29544.989% |
| Savara Inc. | 153 Thousand USD | 160308.497% |
| Curis, Inc. | -23.88 Million USD | -926.161% |
| Daré Bioscience, Inc. | -5.15 Million USD | -4652.292% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -31487.012% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -3848.438% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 20785.148% |
| BeiGene, Ltd. | -2.25 Billion USD | 89.121% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 2086.619% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 59.698% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | -32.078% |
| Erasca, Inc. | -37.21 Million USD | -558.639% |
| bluebird bio, Inc. | 108.57 Million USD | 325.768% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -18932.559% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 164.718% |
| DBV Technologies S.A. | -126.98 Million USD | -93.028% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -18932.559% |
| Moderna, Inc. | -2.9 Billion USD | 91.568% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -2267.842% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -2155.42% |
| Molecular Templates, Inc. | 707 Thousand USD | 34770.297% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -681.355% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 170.719% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -198.7% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -167.218% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -659.541% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -613.053% |
| MacroGenics, Inc. | -66.98 Million USD | -265.931% |
| RenovoRx, Inc. | -1.17 Million USD | -20796.76% |
| Adicet Bio, Inc. | -138.78 Million USD | -76.615% |
| Prime Medicine, Inc. | -27.94 Million USD | -777.274% |
| Aditxt, Inc. | 18.12 Million USD | 1452.688% |
| Adagene Inc. | -87.62 Million USD | -179.729% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -5784.605% |
| Quantum-Si incorporated | -118.55 Million USD | -106.752% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 780.792% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -3179.54% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -405.306% |
| SciSparc Ltd. | -2.06 Million USD | -11770.169% |
| Vericel Corporation | 1.27 Million USD | 19294.91% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1944.072% |
| Minerva Neurosciences, Inc. | 41 Million USD | 697.789% |
| Generation Bio Co. | 31.44 Million USD | 879.442% |
| Astria Therapeutics, Inc. | -175.36 Million USD | -39.777% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -692.675% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 310.235% |
| Invivyd, Inc. | -198.47 Million USD | -23.501% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -171.54% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -10123.139% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -246.262% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -3491.487% |
| 2seventy bio, Inc. | 181.71 Million USD | 234.892% |
| ADMA Biologics, Inc. | 90.06 Million USD | 372.155% |
| Clene Inc. | 3.34 Million USD | 7438.892% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -2598.745% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -1039.505% |
| GeoVax Labs, Inc. | -6.45 Million USD | -3698.77% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 28.77% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -842.777% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 237.966% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -5890.834% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 5000.42% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -4605.682% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -88.113% |
| Evaxion Biotech A/S | 5.28 Million USD | 4736.396% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -117.752% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -86.725% |
| Trevena, Inc. | 2.25 Million USD | 10955.58% |
| Surrozen, Inc. | -32.66 Million USD | -650.426% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -375.867% |
| Cingulate Inc. | 3.08 Million USD | 8051.483% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -8245.897% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 3510.589% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -2538.177% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -209.014% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -86.47% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -132.248% |
| Clearmind Medicine Inc. | -3.94 Million USD | -6117.133% |
| Kronos Bio, Inc. | -36.05 Million USD | -579.866% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 2705.155% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 16910.538% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -351.782% |
| Statera Biopharma, Inc. | 14.41 Million USD | 1800.278% |
| ImmunityBio, Inc. | 618.22 Million USD | 139.649% |
| Korro Bio, Inc. | -132.94 Million USD | -84.379% |
| Kineta, Inc. | -4.54 Million USD | -5297.908% |
| BioVie Inc. | -17.73 Million USD | -1282.327% |
| Codexis, Inc. | -43.27 Million USD | -466.474% |
| Celularity Inc. | 65.19 Million USD | 476.007% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -7634.901% |
| Celcuity Inc. | 6.78 Million USD | 3713.454% |
| Virax Biolabs Group Limited | -3.36 Million USD | -7184.49% |
| Cibus, Inc. | -8.07 Million USD | -2934.402% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -5696.146% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 5463.654% |
| IN8bio, Inc. | -16.38 Million USD | -1395.631% |
| Kodiak Sciences Inc. | -103.87 Million USD | -135.975% |
| Annexon, Inc. | -193.75 Million USD | -26.51% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 680986.111% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -1300.76% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -6877.484% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 123.25% |
| Eyenovia, Inc. | 1.25 Million USD | 19573.95% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 1011.054% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -7458.403% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -637.267% |
| Arcellx, Inc. | -296.95 Million USD | 17.457% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -1156.634% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -316.338% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -1082.607% |
| Moolec Science SA | 117.61 Thousand USD | 208506.169% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -538.347% |
| Geron Corporation | 14.76 Million USD | 1760.585% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -546.445% |
| Royalty Pharma plc | 5.65 Billion USD | 104.332% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -73.326% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -3406.999% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -4470.678% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -74.176% |
| Humacyte, Inc. | -22.48 Million USD | -990.096% |
| Structure Therapeutics Inc. | -124.33 Million USD | -97.138% |
| 89bio, Inc. | -289.05 Million USD | 15.199% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -871.076% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -13647.56% |
| Genelux Corporation | -6.89 Million USD | -3452.964% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -689.204% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 393.208% |
| Notable Labs, Ltd. | -9.77 Million USD | -2407.355% |
| Liquidia Corporation | -80.17 Million USD | -205.726% |
| Mustang Bio, Inc. | -3.73 Million USD | -6461.001% |
| Immunovant, Inc. | -635.22 Million USD | 61.412% |
| Quantum-Si incorporated | -118.55 Million USD | -106.752% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -1295.576% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -5816.462% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 3153.681% |
| Acasti Pharma Inc. | -23 Million USD | -965.503% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -7179.546% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -1408.483% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -77.958% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -7765.55% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -1002.55% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -1220.044% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | -44.803% |
| PepGen Inc. | -60.67 Million USD | -304.02% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -966.848% |
| United Therapeutics Corporation | -507.7 Million USD | 51.72% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -1181.601% |
| Solid Biosciences Inc. | -47.75 Million USD | -413.338% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -28333.143% |
| Immuneering Corporation | -54.94 Million USD | -346.134% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -5731.324% |
| Silo Pharma, Inc. | -3.52 Million USD | -6855.096% |
| Belite Bio, Inc | -87.27 Million USD | -180.871% |
| XOMA Corporation | -29 Million USD | -745.238% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -246.718% |
| Bionomics Limited | 227 Million USD | 207.977% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -110.797% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -9577.023% |
| uniQure N.V. | -102.95 Million USD | -138.093% |
| Cassava Sciences, Inc. | -121.13 Million USD | -102.35% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -5784.605% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 698.567% |
| Forte Biosciences, Inc. | -11.96 Million USD | -1949.319% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -7821.886% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 231344.34% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -7458.403% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 2852.6% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -3205.272% |
| Altimmune, Inc. | -134.48 Million USD | -82.262% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 223.757% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -9577.023% |
| Compugen Ltd. | -12.9 Million USD | -1799.558% |
| Peak Bio, Inc. | 10.34 Million USD | 2470.554% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -86514.488% |
| Benitec Biopharma Inc. | -50.58 Million USD | -384.597% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -134.928% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 1347.742% |
| Zura Bio Limited | -99.8 Million USD | -145.595% |
| PolyPid Ltd. | 6.17 Million USD | 4072.755% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 430.706% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 1347.742% |
| Instil Bio, Inc. | 75.35 Million USD | 425.273% |
| argenx SE | -2.02 Billion USD | 87.918% |
| Immunome, Inc. | -97.02 Million USD | -152.624% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -989.66% |
| Verona Pharma plc | -220.44 Million USD | -11.194% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -241.663% |
| Shattuck Labs, Inc. | -121.42 Million USD | -101.87% |
| CervoMed Inc. | -7.79 Million USD | -3045.436% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | -32.14% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -5505.282% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -86.063% |
| Moolec Science SA | 117.61 Thousand USD | 208506.169% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -10613.351% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 1641.786% |
| AnaptysBio, Inc. | -18.15 Million USD | -1250.444% |
| Design Therapeutics, Inc. | -18.15 Million USD | -1250.518% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -248.274% |
| NeurAxis, Inc. | 145.7 Thousand USD | 168335.415% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 2282.327% |
| Lumos Pharma, Inc. | -28.49 Million USD | -760.278% |
| Achilles Therapeutics plc | -126.92 Million USD | -93.123% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -241.663% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -37281.087% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -1079.942% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 16910.538% |
| Nutriband Inc. | -251.65 Thousand USD | -97302.019% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -1761.051% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -3194.61% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 172.052% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 1132.732% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 45.221% |
| Palisade Bio, Inc. | -12.06 Million USD | -1931.99% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -74.697% |
| Beam Therapeutics Inc. | -262.72 Million USD | 6.7% |
| Neurogene Inc. | -131.95 Million USD | -85.76% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 1223.574% |
| AEON Biopharma, Inc. | -4.88 Million USD | -4922.93% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 35.015% |
| Sesen Bio, Inc. | -112.55 Million USD | -117.781% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -145.463% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -10340.401% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -528.092% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -194.324% |
| Athira Pharma, Inc. | -88.99 Million USD | -175.418% |
| Vaccinex, Inc. | -1.28 Million USD | -18930.978% |
| HCW Biologics Inc. | 2.85 Million USD | 8680.567% |
| XOMA Corporation | -29 Million USD | -745.238% |
| Nektar Therapeutics | 210.24 Million USD | 216.59% |
| Arvinas, Inc. | -313.8 Million USD | 21.887% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 15203.858% |
| Merus N.V. | -192.88 Million USD | -27.081% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 508.634% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -3432.992% |
| Rezolute, Inc. | -68.16 Million USD | -259.581% |
| Clene Inc. | 3.34 Million USD | 7438.892% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -1758.793% |
| BeyondSpring Inc. | -13.75 Million USD | -1682.036% |
| Synlogic, Inc. | -6.68 Million USD | -3566.702% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 21715.432% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -2799.101% |
| Peak Bio, Inc. | 10.34 Million USD | 2470.554% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -197.402% |
| Krystal Biotech, Inc. | -350.23 Million USD | 30.013% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 297.478% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | -45.044% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -7663.947% |
| MannKind Corporation | 143.89 Million USD | 270.341% |
| Ikena Oncology, Inc. | -109.15 Million USD | -124.558% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -3137.604% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -640.541% |
| Gossamer Bio, Inc. | 180.35 Million USD | 235.909% |
| CohBar, Inc. | -5.93 Million USD | -4033.032% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -723.985% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 5468.353% |
| Legend Biotech Corporation | -949.39 Million USD | 74.182% |
| Mural Oncology plc | -255.84 Million USD | 4.192% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 860.885% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -5103.516% |
| Disc Medicine, Inc. | -358.28 Million USD | 31.585% |
| Champions Oncology, Inc. | 4.81 Million USD | 5193.911% |
| REGENXBIO Inc. | 54.76 Million USD | 547.559% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -91053.819% |
| Anavex Life Sciences Corp. | -151.02 Million USD | -62.305% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -2619.916% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -203.805% |
| Vaxart, Inc. | -8.24 Million USD | -2874.384% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -388.48% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -92.756% |
| Cellectis S.A. | -43.85 Million USD | -458.931% |
| Longeveron Inc. | -2.9 Million USD | -8329.127% |
| Repare Therapeutics Inc. | -107.85 Million USD | -127.261% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 125.312% |
| Inozyme Pharma, Inc. | 12 Million USD | 2141.978% |
| Revolution Medicines, Inc. | -608.2 Million USD | 59.698% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -19828.374% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 7.543% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -63.334% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -1466.556% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -33024.189% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 97.437% |
| Denali Therapeutics Inc. | -74.86 Million USD | -227.415% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1944.072% |
| Veru Inc. | 4.77 Million USD | 5228.046% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -2079.611% |
| Cingulate Inc. | 3.08 Million USD | 8051.483% |
| Passage Bio, Inc. | 4.58 Million USD | 5446.107% |
| Context Therapeutics Inc. | -14.44 Million USD | -1596.346% |
| Exicure, Inc. | 5.84 Million USD | 4290.785% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | -6.4% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -519.457% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 1662.163% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -316.72% |
| Nuvalent, Inc. | -335.38 Million USD | 26.915% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 14233.264% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -229.098% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -2657.244% |
| OmniAb, Inc. | 9.2 Million USD | 2763.468% |
| Anew Medical, Inc. | 1.43 Million USD | 17211.692% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 1596.293% |
| Lipocine Inc. | -4.75 Million USD | -5055.416% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -123.184% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 1709.343% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -383.861% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 1084.73% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -3547.061% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -272.368% |
| Ocugen, Inc. | -32.52 Million USD | -653.725% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -186.438% |
| Q32 Bio Inc. | -37.94 Million USD | -545.934% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -38931.688% |
| Alumis Inc. Common Stock | -13.52 Million USD | -1711.804% |
| Equillium, Inc. | -22.39 Million USD | -994.672% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -858.694% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -651.282% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -98772.194% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 282.867% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 7764.759% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 74731.06% |
| Dominari Holdings Inc. | 195 Thousand USD | 125802.051% |
| Edesa Biotech, Inc. | -5.26 Million USD | -4553.943% |
| vTv Therapeutics Inc. | -8.91 Million USD | -2648.895% |
| Bio-Techne Corporation | 267.74 Million USD | 191.549% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -1412.24% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -107.563% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -2817.042% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -1837.546% |
| Nkarta, Inc. | 57.29 Million USD | 527.789% |
| BioCardia, Inc. | 212 Thousand USD | 115722.17% |
| Iterum Therapeutics plc | 13.43 Million USD | 1924.074% |